Search Result "T315I mutation"


Inhibitors of ABL and the ABL-T315I Mutation

Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 905-921
Author(s): Glenn Noronha, Jianguo Cao, Chun P. Chow, Elena Dneprovskaia, Richard M. Fine, John Hood, Xinshan Kang, Boris Klebansky, Dan Lohse, Chi Ching Mak, Andrew McPherson, Moorthy S.S. Palanki, Ved P. Pathak, Joel Renick, Richard Soll, Binqi Zeng

Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2146-2157
Author(s): X. Y. Lu, Q. Cai, K. Ding

Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 347-355
Author(s): Shinya Kimura

Research Article open access plus

Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 17 Issue: 1 Year: 2020 Page: 48-54
Author(s): Reni Widyastuti,Ikhwan Rinaldi,Melva Louisa,Riki Nova,Instiaty Instiaty,Rizky Priambodo

Targeting Drug Resistant Mutations Using Novel Binding Interactions - Lessons Learned from Abl-T315I and their Implications in D

Ebook: Young People’s Visions of the World
Volume: 3 Year: 2010
Author(s): Glen Noronha,Jianguo Cao,Chun Chow,Elena Dneprovskaia,Linda Hwang,Dan Lohse,Chi Ching Mak,Andrew McPherson,Richard M. Fine,Xinshan Kang,Boris Klebansky,Moorthy S.S. Palanki,Ved P. Pathak,Joel Renick,Richard Soll,Binqi Zeng

New Opportunities to Treat the T315I-Bcr-Abl Mutant in Chronic Myeloid Leukaemia: Tyrosine Kinase Inhibitors and Molecules that Act by Alternative Mechanisms

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1220-1245
Author(s): S. Schenone, C. Brullo, M. Botta

Review Article

Ponatinib: A Review of Efficacy and Safety

Journal: Current Cancer Drug Targets
Volume: 18 Issue: 9 Year: 2018 Page: 847-856
Author(s): Fulvio Massaro,Matteo Molica,Massimo Breccia

In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations

Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 396-404
Author(s): R. Rajasekaran, C. George Priya Doss, G. Arun Prasad, Rao Sethumadhavan

Emerging Therapies in Chronic Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 12 Issue: 5 Year: 2012 Page: 458-470
Author(s): J. Gora-Tybor

Review Article

Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 4 Year: 2019 Page: 333-345
Author(s): Vivek Kumar Singh,Mohane Selvaraj Coumar

Previous   Next

Go To   Results 1 - 1 of 184

Filter Result

Volume Year
Ads
© 2022 Bentham Science Publishers | Privacy Policy